Literature DB >> 12424042

Correlating the efficacy of knee viscosupplementation with osteoarthritic changes on roentgenological examination.

E M Toh1, P S Prasad, D Teanby.   

Abstract

This study was designed to identify the roentgenological changes of the knee that correlated with an unfavourable outcome when treated with an intra-articular knee viscoelastic supplementation. A prospective cohort of 60 patients receiving a standard course of intra-articular knee viscoelastic supplementation with a commercial uncross-linked hyaluronic acid derivative of an intermediate molecular weight were studied. Follow up was for 12 weeks post-treatment with clinical improvement measured using the Western Ontario and McMasters Universities Osteoarthritis Index. X-Rays of the relevant knee were viewed and graded for the severity of joint space, osteophyte, tibial spine, sclerosis, cyst formation, alignment and general severity by an observer blinded to the outcome of the treatment. There were no appreciable differences noted in the age, sex, length of follow up, pre-treatment, the severity of symptoms before treatment and number of intra-articular injections given per course in each X-ray category identified. There was a significant amount of improvement in patients with a minor loss of medial and lateral joint space in all outcome measures. Minimal changes in tibial spine and global appearance also indicated a positive outcome in stiffness, pain and overall improvement. Thus, patients with moderate to severe osteoarthritic changes in joint space on roentgenological examination would not significantly benefit from intra-articular knee viscoelastic supplementation. In addition, we feel that changes in the tibial spine and global appearance are not reviewed consistently enough to be included as part of our recommendation. As such, we conclude that only patients with a minimal to mild loss in joint space on roentgenological examination should form part of the target group who are likely to benefit from intra-articular knee viscoelastic supplementation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424042     DOI: 10.1016/s0968-0160(02)00040-6

Source DB:  PubMed          Journal:  Knee        ISSN: 0968-0160            Impact factor:   2.199


  7 in total

Review 1.  Intra-articular treatments in osteoarthritis: from the symptomatic to the structure modifying.

Authors:  L Gossec; M Dougados
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

2.  National, multicentre, prospective study of quality of life in patients with osteoarthritis of the knee treated with hylane G-F 20.

Authors:  Anne-Christine Rat; Cédric Baumann; Francis Guillemin
Journal:  Clin Rheumatol       Date:  2011-04-12       Impact factor: 2.980

3.  EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis.

Authors:  Thierry Conrozier; Jordi Monfort; Xavier Chevalier; Raghu Raman; Pascal Richette; Demirhan Diraçoglù; Hervé Bard; Dominique Baron; Jörg Jerosch; Alberto Migliore; Yves Henrotin
Journal:  Cartilage       Date:  2018-06-21       Impact factor: 4.634

Review 4.  Viscosupplementation for the treatment of osteoarthritis of the knee.

Authors:  N Bellamy; J Campbell; V Robinson; T Gee; R Bourne; G Wells
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

5.  Safety and Predictive Factors of Short-Term Efficacy of a Single Injection of Mannitol-Modified Cross-Linked Hyaluronic Acid in Patients with Trapeziometacarpal Osteoarthritis. Results of a Multicentre Prospective Open-Label Pilot Study (INSTINCT Trial).

Authors:  Jérémy Dauvissat; Christophe Rizzo; Henri Lellouche; Jérôme Porterie; Sylvie Melac-Ducamp; Vincent Locquet; Vincent Travers; Bernard Maillet; Thierry Conrozier
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2018-06-21

6.  Impact of obesity, structural severity and their combination on the efficacy of viscosupplementation in patients with knee osteoarthritis.

Authors:  Thierry Conrozier; Florent Eymard; Mickael Chouk; Xavier Chevalier
Journal:  BMC Musculoskelet Disord       Date:  2019-08-17       Impact factor: 2.362

7.  Intra-articular hyaluronic Acid as treatment in elderly and middle-aged patients with knee osteoarthritis.

Authors:  Demet Uçar; Demirhan Dıraçoğlu; Türker Süleyman; Nalan Capan
Journal:  Open Rheumatol J       Date:  2013-07-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.